Judy Bruner - Varian Medical Independent Director

Director

Ms. Judy Bruner serves as Independent Director of the Company. She Served Positions at SanDisk Corporationrationration, a global leader in flash memory storage solutions, Executive Vice President, Administration and Chief Financial Officer and Member of Board of Directors .Senior Vice President and Chief Financial Officer, Palm, Inc., a manufacturer of personal digital assistants, She is Vice President, Finance Corporationrationrate Controller, 3Com Corporationrationration, a digital electronics manufacturer Other Current Public Company Board Memberships Brocade Communications Systems, Inc., a technology company specializing in data and storage networking products Applied Materials, Inc., a provider of engineering solutions Rapid7, a security data and analytics solutions provider. since 2016.
Age 61
Tenure 8 years
Phone650 493-4000
Webwww.varian.com
Bruner served as the chief financial officer for SanDisk from 2004 to this year when it was acquired by Western Digital . She also served as senior vice president and chief financial officer for Palm, Inc. from 1999 to 2004. She has held prior management positions in finance and administration with 3Com Corporationrationrationration, Ridge Computers, Inc. and Hewlett Packard Company. Bruner earned an MBA at the University of Santa Clara in 1986 and a BA in Economics at UCLA in 1980. Bruner is also a member of the Board of Directors of Brocade Communications, Inc., where she serves as chair of the audit committee, a member of the Board of Directors of Applied Materials and a member of the board of trustees of the Computer History Museum. She also served in the past on the boards of Vermillion, Inc. and SanDisk Corporationrationrationration, before assuming her executive role there.

Varian Medical Management Efficiency

The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Debt can assist Varian Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Varian Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Varian Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Varian to invest in growth at high rates of return. When we think about Varian Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Claudio CorninForsys Metals Corp
N/A
Kimberly AlexyWestern Digital
47
Steven OBrienArrow Electronics
N/A
Kathleen CoteWestern Digital
69
Sanjay MehrotraWestern Digital
55
Stephanie StreeterWestern Digital
59
Paul MatysekForsys Metals Corp
N/A
John HansonArrow Electronics
74
Martha KeethArrow Electronics
73
Philip AshermanArrow Electronics
67
Matthew MassengillWestern Digital
55
Henry DeNeroWestern Digital
70
Paula PriceWestern Digital
55
Richard HillArrow Electronics
69
Thomas AllenForsys Metals Corp
N/A
Michael LambertWestern Digital
69
Stephen PatrickArrow Electronics
71
Martin ColeWestern Digital
61
Steven GunbyArrow Electronics
63
Tunc DolucaWestern Digital
59
Laurel KrzeminskiArrow Electronics
66
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Varian Medical Systems (VAR) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Varian Medical Systems Leadership Team

Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Laret, Independent Director
Regina Dugan, Independent Director
Jose Baselga, Director
Erich Reinhardt, Independent Director
Timothy Guertin, Independent Vice Chairman of the board
Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer
J Bruff, Chief Financial Officer, Senior Vice President - Finance
Anat Ashkenazi, Independent Director
Susan Bostrom, Independent Director
JeanLuc Butel, Independent Director
Kevin OReilly, Senior Vice President and President Oncology Systems
Sunny Sanyal, Sr. VP and President of Imaging Components Bus.es
Dow Wilson, President, Chief Executive Officer, Director
Francis Facchini, President Interventional Solutions Business
Clarence Verhoef, Senior Vice President - Finance, Corporate Controller
Jeffrey Balser, Independent Director
R Eckert, Independent Chairman of the Board
Venkatraman Thyagarajan, Independent Director
Anshul Maheshwari, Vice President Treasurer, IR Contact Officer
David Illingworth, Independent Director
Judy Bruner, Independent Director
Gary Bischoping, Chief Financial Officer, Senior Vice President - Finance
Juarez Monroeas, Senior Vice President - Human Resources and Chief People Officer
Elisha Finney, CFO and Executive VP of Fin.
John Kuo, Senior Vice President, General Counsel, Corporate Secretary
Rafael Torres, Senior Vice President - Business Development and Strategy
Christopher Toth, President, Chief Executive Officer, Chief Operating Officer
Mike Bruff, Vice president, IR Contact Officer
Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary
Andrew Eckert, Independent Chairman of the Board
Phillip Febbo, Chief Medical Officer, Director
Spencer Sias, Vice President - Corporate Communications and Investor Relations
Chris Toth, President - Varian Oncology Systems
Ruediger NaumannEtienne, Independent Director
Michelle Beau, Independent Director

Varian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Varian Medical Systems information on this page should be used as a complementary analysis to other Varian Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories